Lilly(Eli) & Co
NYSE:LLY 10:45:23 AM EDT
| Market Cap (Intraday) | 288.94B |
| Current PE | 50.77 |
| Forward PE | 37.96 |
| 2yr Forward PE | 32.59 |
| 10-Day MA | $309.79 |
| 50-Day MA | $315.33 |
| 200-Day MA | $279.49 |
Lilly(Eli) & Co Stock, NYSE:LLY
Lilly Corporate Center, Indianapolis, Indiana 46285
United States of America
Phone: +1.317.276.2000
Number of Employees: 35000
Description
Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. The firm's products consist of Diabetes, Oncology, Immunology, Neuroscience, and Other therapies. The Diabetes products include Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta, and Trulicity. The Oncology products consist of Alimta, Cyramza, Erbitux, Retevmo, Tyvyt, and Verzenio. The Immunology products include Olumiant and Taltz. The Neuroscience products consist of Cymbalta, Emgality, Reyvow, and Zyprexa. The Other therapies include Bamlanivimab, Cialis, and Forteo. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.